Nomura Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.93M | Buy |
32,343
+29,261
| +949% | +$2.45M | ﹤0.01% | 967 |
|
|
2026
Q1 | $247K | Sell |
3,082
-74,556
| -96% | -$6.15M | ﹤0.01% | 1531 |
|
|
2025
Q4 | $6.62M | Buy |
77,638
+11,841
| +18% | +$972K | 0.01% | 686 |
|
|
2025
Q3 | $5.12M | Buy |
+65,797
| New | +$5.14M | 0.01% | 765 |
|
|
2025
Q2 | – | Sell |
-3,683
| Closed | -$267K | – | 1618 |
|
|
2025
Q1 | $267K | Buy |
+3,683
| New | +$264K | ﹤0.01% | 1626 |
|
|
2024
Q4 | – | Sell |
-6,729
| Closed | -$471K | – | 2243 |
|
|
2024
Q3 | $444K | Sell |
6,729
-30,505
| -82% | -$2.22M | ﹤0.01% | 1273 |
|
|
2024
Q2 | $3.44M | Sell |
37,234
-268,255
| -88% | -$23.8M | 0.01% | 759 |
|
|
2024
Q1 | $29.2M | Buy |
305,489
+293,249
| +2,396% | +$24.6M | 0.07% | 190 |
|
|
2023
Q4 | $933K | Buy |
+12,240
| New | +$852K | ﹤0.01% | 1195 |
|
|
2023
Q3 | – | Sell |
-2,465
| Closed | -$233K | – | 1461 |
|
|
2023
Q2 | $233K | Buy |
+2,465
| New | +$214K | ﹤0.01% | 1152 |
|
|
2022
Q4 | – | Sell |
-3,700
| Closed | -$306K | – | 1561 |
|
|
2022
Q3 | $306K | Buy |
+3,700
| New | +$356K | ﹤0.01% | 1183 |
|
|
2022
Q2 | – | Sell |
-12,166
| Closed | -$1.5M | – | 1918 |
|
|
2022
Q1 | $1.5M | Buy |
+12,166
| New | +$1.36M | ﹤0.01% | 973 |
|
|
2021
Q4 | – | Sell |
-9,466
| Closed | -$1.06M | – | 2310 |
|
|
2021
Q3 | $1.06M | Buy |
9,466
+7,001
| +284% | +$799K | ﹤0.01% | 1102 |
|
|
2021
Q2 | $255K | Sell |
2,465
-385
| -14% | -$36.3K | ﹤0.01% | 1646 |
|
|
2021
Q1 | $238K | Sell |
2,850
-20,721
| -88% | -$1.75M | ﹤0.01% | 1596 |
|
|
2020
Q4 | $2.15M | Buy |
23,571
+6,724
| +40% | +$558K | ﹤0.01% | 826 |
|
|
2020
Q3 | $1.34M | Sell |
16,847
-24,794
| -60% | -$1.93M | ﹤0.01% | 748 |
|
|
2020
Q2 | $2.88M | Sell |
41,641
-102,752
| -71% | -$7.3M | 0.01% | 492 |
|
|
2020
Q1 | $9.08M | Buy |
+144,393
| New | +$10.4M | 0.04% | 245 |
|
|
2019
Q1 | – | Sell |
-91,488
| Closed | -$4.66M | – | 1185 |
|
|
2018
Q4 | $4.66M | Buy |
+91,488
| New | +$4.63M | 0.02% | 524 |
|
|
2018
Q3 | – | Sell |
-18,720
| Closed | -$908K | – | 1353 |
|
|
2018
Q2 | $908K | Sell |
18,720
-30,756
| -62% | -$1.44M | ﹤0.01% | 880 |
|
|
2018
Q1 | $2.3K | Buy |
49,476
+1,065
| +2% | +$46.2K | ﹤0.01% | 798 |
|
|
2017
Q4 | $1.82M | Buy |
48,411
+1,437
| +3% | +$52.7K | ﹤0.01% | 922 |
|
|
2017
Q3 | $1.71M | Sell |
46,974
-606
| -1% | -$23.1K | ﹤0.01% | 894 |
|
|
2017
Q2 | $1.88M | Buy |
47,580
+30,378
| +177% | +$1.11M | ﹤0.01% | 853 |
|
|
2017
Q1 | $539K | Sell |
17,202
-18,138
| -51% | -$568K | ﹤0.01% | 893 |
|
|
2016
Q4 | $1.1M | Buy |
+35,340
| New | +$1.15M | ﹤0.01% | 1034 |
|
|
2016
Q2 | – | Sell |
-11,430
| Closed | -$335K | – | 1349 |
|
|
2016
Q1 | $335K | Buy |
+11,430
| New | +$315K | ﹤0.01% | 1006 |
|
|
2015
Q3 | – | Sell |
-138,084
| Closed | -$3.29M | – | 1719 |
|
|
2015
Q2 | $3.29M | Buy |
138,084
+123,384
| +839% | +$2.78M | 0.01% | 596 |
|
|
2015
Q1 | $350K | Sell |
14,700
-163,422
| -92% | -$3.67M | ﹤0.01% | 1235 |
|
|
2014
Q4 | $3.78M | Buy |
178,122
+61,692
| +53% | +$1.24M | 0.01% | 736 |
|
|
2014
Q3 | $1.98M | Buy |
+116,430
| New | +$1.84M | 0.01% | 1111 |
|
|
2014
Q2 | – | Sell |
-231,534
| Closed | -$2.86M | – | 2824 |
|
|
2014
Q1 | $2.86M | Buy |
231,534
+182,574
| +373% | +$2.11M | ﹤0.01% | 1003 |
|
|
2013
Q4 | $534K | Sell |
48,960
-391,914
| -89% | -$4.42M | ﹤0.01% | 1247 |
|
|
2013
Q3 | $5.13M | Buy |
440,874
+286,830
| +186% | +$3.36M | 0.03% | 472 |
|
|
2013
Q2 | $1.73M | Buy |
+154,044
| New | +$1.82M | 0.01% | 747 |
|
Other funds holding EW
Nomura Holdings's EW Position: Q2 2026 in Review
Nomura Holdings increased its Edwards Lifesciences (EW) stake by 949% in Q2 2026, buying an estimated $2.45M and bringing the position to 32,343 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #967.
Nomura Holdings first reported a position in EW in Q2 2013 and has held it in 36 quarters since. The position peaked at $29.2M in Q1 2024. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Nomura Holdings held 32,343 shares of Edwards Lifesciences worth $2.93M as of Q2 2026.
- Nomura Holdings bought 29,261 Edwards Lifesciences shares in Q2 2026, an estimated $2.45M.
- Edwards Lifesciences made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #967 holding.
- Nomura Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 36 quarters since.
- Nomura Holdings's Edwards Lifesciences position peaked at $29.2M in Q1 2024.
- 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.